Stock A359090 C&R RESEARCH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company C&R Research Inc.

Equities

A359090

KR7359090008

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 31/05/2024 am IST 		5-day change 1st Jan Change
1,745 KRW +1.04% Intraday chart for C&R Research Inc. +4.80% +46.64%
2023 C&R Research Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
2021 C&R Research Co., Ltd. completed the acquisition of NH Special Purpose Acquisition 17 Company in a reverse merger transaction. CI

Business Summary

C&R Research Inc is a Korea-based company is mainly engaged in the clinical trial agency and drug development business. The Company is mainly engaged in the provision of comprehensive early-stage clinical services in the areas of medical writing, regulatory matters, data management, biostatistics and others. The Company is mainly engaged in the provision of consulting services including initial clinical development, clinical trial development, global clinical trial development and others. In addition, the Company is also engaged in the operation of clinical trial training center.

Number of employees: 483

Managers

Managers TitleAgeSince
Moon-Tae Yoon CEO
 Chief Executive Officer 72 08/21/08

Members of the board

Members of the board TitleAgeSince
Moon-Tae Yoon CEO
 Chief Executive Officer 72 08/21/08
Hong-In No BRD
 Director/Board Member 64 -
Jung-Hee Park BRD
 Director/Board Member 60 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 56,380,891 20,016,391 ( 35.50 %) 471 ( 0.000835 %) 35.50 %

Shareholders

NameEquities%Valuation
Moon-Tae Yoon
41.08 %
22,564,756 41.08 % 31 M ₩
Eun-sook Kim
9.293 %
5,103,933 9.293 % 7 M ₩
Byung-in Yoon
7.337 %
4,029,420 7.337 % 5 M ₩
Byung-sun Yoon
7.337 %
4,029,420 7.337 % 5 M ₩
Kolon Investment, Inc.
3.783 %
2,077,492 3.783 % 3 M ₩
Yun-ho Kim
0.2039 %
112,000 0.2039 % 152 348 ₩
Deok Hyeon Kim
0.007580 %
4,163 0.007580 % 5 663 ₩
C&R RESEARCH INC.
0.000858 %
471 0.000858 % 641 ₩

Holdings

NameEquities%Valuation
C&R RESEARCH INC.
0.00%
 471 0.00% 641 $

Company contact information

C&R Research, Inc.

C&R Building 412 Yeoksam-ro

06199, Seoul

+

http://www.cnrres.com
address C&R Research Inc.(A359090)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
C&R RESEARCH INC. Stock C&R Research Inc.
+46.64% 7.11Cr
MODERNA, INC. Stock Moderna, Inc.
+43.36% 5.46TCr
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-5.31% 3.99TCr
LONZA GROUP AG Stock Lonza Group AG
+37.40% 3.88TCr
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+14.75% 2.69TCr
CELLTRION, INC. Stock Celltrion, Inc.
-12.56% 2.62TCr
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.45% 1.88TCr
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.12% 1.22TCr
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.04% 1.22TCr
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.04% 1.19TCr
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. A359090 Stock
  4. Company C&R Research Inc.